“Appropriate people at higher risk should be vaccinated, and this will not only benefit the vaccinated person, but will ...

Shifts in RSV testing methodology, which were accelerated by changes related to the COVID-19 pandemic, mirror shifts seen in ...

Protection against RSV derived from preF IgG antibodies waned 6 months after infection in an analysis of patients with confirmed disease and household contacts.

British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to extend the ...

Adults as young as 50 may now qualify for an respiratory synctial virus vaccine if they have certain health conditions.

RSV is causing thousands of infant deaths in India yearly, yet remains underdiagnosed. Experts stress the urgent need for ...

the cough associated with croup sounds barky, or seal-like. Additionally, the high-pitched noise during breathing in is indicative of upper airway narrowing. Croup symptoms include: Cold symptoms such ...

Leading oncology centers in the United States engaged to conduct the Phase 2 Antiviral Trial and further advance the development of PUL-042 HOUSTON, TX, UNITED STATES, July 8, 2025 /EINPresswire.com/ ...

The Trump administration appears to be expanding RSV vaccinations to some adults starting at age 50 instead of 60. Health Secretary Robert F. Kennedy Jr. recently fired the government vaccine ...

Re-recording mixer Andrew Koyama and supervising sound editors Mark Stoeckinger, Luke Gibleon, and Casey Genton talk about creating the soundscape.

Washtenaw County Breathing problems, seasonal allergies, asthma flare-ups, respiratory illnesses, stomach viruses, outdoor injuries.

The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 cause of hospitalization in infants.